These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7958854)

  • 1. p21-containing cyclin kinases exist in both active and inactive states.
    Zhang H; Hannon GJ; Beach D
    Genes Dev; 1994 Aug; 8(15):1750-8. PubMed ID: 7958854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
    Xiong Y; Zhang H; Beach D
    Genes Dev; 1993 Aug; 7(8):1572-83. PubMed ID: 8101826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y; Jenkins CW; Nichols MA; Xiong Y
    Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21 is a universal inhibitor of cyclin kinases.
    Xiong Y; Hannon GJ; Zhang H; Casso D; Kobayashi R; Beach D
    Nature; 1993 Dec; 366(6456):701-4. PubMed ID: 8259214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Cayrol C; Ducommun B
    Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells.
    Poon RY; Hunter T
    Oncogene; 1998 Mar; 16(10):1333-43. PubMed ID: 9546435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
    Cayrol C; Knibiehler M; Ducommun B
    Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design.
    Kontopidis G; Wu SY; Zheleva DI; Taylor P; McInnes C; Lane DP; Fischer PM; Walkinshaw MD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1871-6. PubMed ID: 15681588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.
    Zhang H; Xiong Y; Beach D
    Mol Biol Cell; 1993 Sep; 4(9):897-906. PubMed ID: 7903056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.
    Gonzales AJ; Goldsworthy TL; Fox TR
    Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
    Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
    Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
    Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
    Sekiguchi T; Hunter T
    Oncogene; 1998 Jan; 16(3):369-80. PubMed ID: 9467962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.
    Watanabe H; Pan ZQ; Schreiber-Agus N; DePinho RA; Hurwitz J; Xiong Y
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1392-7. PubMed ID: 9465025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.